Literature DB >> 26363366

IL-21-driven neoplasms in SJL mice mimic some key features of human angioimmunoblastic T-cell lymphoma.

Shweta Jain1, Jing Chen2, Alina Nicolae3, Hongsheng Wang1, Dong-Mi Shin4, Elisabeth B Adkins5, Thomas J Sproule6, Caroline M Leeth7, Tomomi Sakai1, Alexander L Kovalchuk1, Mark Raffeld3, Jerrold M Ward1, Jerold E Rehg8, Thomas A Waldmann2, Elaine S Jaffe3, Derry C Roopenian5, Herbert C Morse9.   

Abstract

SJL/J mice exhibit a high incidence of mature B-cell lymphomas that require CD4(+) T cells for their development. We found that their spleens and lymph nodes contained increased numbers of germinal centers and T follicular helper (TFH) cells. Microarray analyses revealed high levels of transcripts encoding IL-21 associated with high levels of serum IL-21. We developed IL-21 receptor (IL21R)-deficient Swiss Jim Lambart (SJL) mice to determine the role of IL-21 in disease. These mice had reduced numbers of TFH cells, lower serum levels of IL-21, and few germinal center B cells, and they did not develop B-cell tumors, suggesting IL-21-dependent B-cell lymphomagenesis. We also noted a series of features common to SJL disease and human angioimmunoblastic T-cell lymphoma (AITL), a malignancy of TFH cells. Gene expression analyses of AITL showed that essentially all cases expressed elevated levels of transcripts for IL21, IL21R, and a series of genes associated with TFH cell development and function. These results identify a mouse model with features of AITL and suggest that patients with the disease might benefit from therapeutic interventions that interrupt IL-21 signaling.
Copyright © 2015 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26363366      PMCID: PMC4630166          DOI: 10.1016/j.ajpath.2015.07.021

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  50 in total

Review 1.  Sleeping with the enemy--endogenous superantigens in humans.

Authors:  D N Posnett; A A Yarilina
Journal:  Immunity       Date:  2001-10       Impact factor: 31.745

Review 2.  T-cell subsets in the germinal center.

Authors:  Roybel R Ramiscal; Carola G Vinuesa
Journal:  Immunol Rev       Date:  2013-03       Impact factor: 12.988

Review 3.  Requirement for reverse immune surveillance for the growth of germinal center-derived murine lymphomas.

Authors:  N M Ponzio; G J Thorbecke
Journal:  Semin Cancer Biol       Date:  2000-10       Impact factor: 15.707

4.  A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity.

Authors:  Carola G Vinuesa; Matthew C Cook; Constanza Angelucci; Vicki Athanasopoulos; Lixin Rui; Kim M Hill; Di Yu; Heather Domaschenz; Belinda Whittle; Teresa Lambe; Ian S Roberts; Richard R Copley; John I Bell; Richard J Cornall; Christopher C Goodnow
Journal:  Nature       Date:  2005-05-26       Impact factor: 49.962

5.  Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages.

Authors:  Roza I Nurieva; Yeonseok Chung; Daehee Hwang; Xuexian O Yang; Hong Soon Kang; Li Ma; Yi-hong Wang; Stephanie S Watowich; Anton M Jetten; Qiang Tian; Chen Dong
Journal:  Immunity       Date:  2008-07-03       Impact factor: 31.745

6.  Anti-IL21 receptor monoclonal antibody (ATR-107): Safety, pharmacokinetics, and pharmacodynamic evaluation in healthy volunteers: a phase I, first-in-human study.

Authors:  Fei Hua; Gail M Comer; Lori Stockert; Bo Jin; John Nowak; Susan Pleasic-Williams; David Wunderlich; John Cheng; Jean S Beebe
Journal:  J Clin Pharmacol       Date:  2013-09-17       Impact factor: 3.126

7.  RGS13 controls g protein-coupled receptor-evoked responses of human mast cells.

Authors:  Geetanjali Bansal; Jeffrey A DiVietro; Hye Sun Kuehn; Sudhir Rao; Karl H Nocka; Alasdair M Gilfillan; Kirk M Druey
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

8.  NOTCH is part of the transcriptional network regulating cell growth and survival in mouse plasmacytomas.

Authors:  Dong-Mi Shin; Daniel J Shaffer; Hongsheng Wang; Derry C Roopenian; Herbert C Morse
Journal:  Cancer Res       Date:  2008-11-15       Impact factor: 12.701

9.  Multiple transcription factor binding sites predict AID targeting in non-Ig genes.

Authors:  Jamie L Duke; Man Liu; Gur Yaari; Ashraf M Khalil; Mary M Tomayko; Mark J Shlomchik; David G Schatz; Steven H Kleinstein
Journal:  J Immunol       Date:  2013-03-20       Impact factor: 5.422

Review 10.  Endogenous mouse mammary tumor viruses (mtv): new roles for an old virus in cancer, infection, and immunity.

Authors:  Michael P Holt; Ethan M Shevach; George A Punkosdy
Journal:  Front Oncol       Date:  2013-11-26       Impact factor: 6.244

View more
  15 in total

Review 1.  Disorders of the JAK/STAT Pathway in T Cell Lymphoma Pathogenesis: Implications for Immunotherapy.

Authors:  Thomas A Waldmann; Jing Chen
Journal:  Annu Rev Immunol       Date:  2017-02-09       Impact factor: 28.527

Review 2.  JAK/STAT pathway directed therapy of T-cell leukemia/lymphoma: Inspired by functional and structural genomics.

Authors:  Thomas A Waldmann
Journal:  Mol Cell Endocrinol       Date:  2017-02-15       Impact factor: 4.102

3.  Transcription factors IRF8 and PU.1 are required for follicular B cell development and BCL6-driven germinal center responses.

Authors:  Hongsheng Wang; Shweta Jain; Peng Li; Jian-Xin Lin; Jangsuk Oh; Chenfeng Qi; Yuanyuan Gao; Jiafang Sun; Tomomi Sakai; Zohreh Naghashfar; Sadia Abbasi; Alexander L Kovalchuk; Silvia Bolland; Stephen L Nutt; Warren J Leonard; Herbert C Morse
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-18       Impact factor: 11.205

Review 4.  Research-Relevant Conditions and Pathology of Laboratory Mice, Rats, Gerbils, Guinea Pigs, Hamsters, Naked Mole Rats, and Rabbits.

Authors:  Timothy K Cooper; David K Meyerholz; Amanda P Beck; Martha A Delaney; Alessandra Piersigilli; Teresa L Southard; Cory F Brayton
Journal:  ILAR J       Date:  2021-12-31       Impact factor: 1.521

5.  Associations of Autoimmunity, Immunodeficiency, Lymphomagenesis, and Gut Microbiota in Mice with Knockins for a Pathogenic Autoantibody.

Authors:  Shweta Jain; Jerrold M Ward; Dong-Mi Shin; Hongsheng Wang; Zohreh Naghashfar; Alexander L Kovalchuk; Herbert C Morse
Journal:  Am J Pathol       Date:  2017-07-17       Impact factor: 4.307

6.  Precocious Interleukin 21 Expression in Naive Mice Identifies a Natural Helper Cell Population in Autoimmune Disease.

Authors:  Elisabeth A Marnik; Xulong Wang; Thomas J Sproule; Giljun Park; Gregory J Christianson; Sarah Kate Lane-Reticker; Shweta Jain; Theodore Duffy; Hongsheng Wang; Gregory W Carter; Herbert C Morse; Derry C Roopenian
Journal:  Cell Rep       Date:  2017-10-03       Impact factor: 9.423

7.  Loss of TRP53 (p53) accelerates tumorigenesis and changes the tumor spectrum of SJL/J mice.

Authors:  Jane A Branca; Benjamin E Low; Ruth L Saxl; Jennifer K Sargent; Rosalinda A Doty; Michael V Wiles; Beth L Dumont; Muneer G Hasham
Journal:  Genes Cancer       Date:  2020

Review 8.  New developments in the pathology of malignant lymphoma: a review of the literature published from May 2015-September 2015.

Authors:  J Han van Krieken
Journal:  J Hematop       Date:  2015-11-19       Impact factor: 0.196

Review 9.  Using Murine Models to Investigate Tumor-Lymphoid Interactions: Spotlight on Chronic Lymphocytic Leukemia and Angioimmunoblastic T-Cell Lymphoma.

Authors:  Tyler A Herek; Christine E Cutucache
Journal:  Front Oncol       Date:  2017-05-02       Impact factor: 6.244

10.  Enhancing the efficacy of glycolytic blockade in cancer cells via RAD51 inhibition.

Authors:  John J Wilson; Kin-Hoe Chow; Nathan J Labrie; Jane A Branca; Thomas J Sproule; Bryant R A Perkins; Elise E Wolf; Mauro Costa; Grace Stafford; Christine Rosales; Kevin D Mills; Derry C Roopenian; Muneer G Hasham
Journal:  Cancer Biol Ther       Date:  2018-09-05       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.